Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z4KX
|
|||
| Former ID |
DCL000801
|
|||
| Drug Name |
Farampator
|
|||
| Synonyms |
CX 691; CX-691; Farampator (USAN/INN); 1-(Benzofurazan-5-ylcarbonyl)piperidine; 2,1,3-benzoxadiazol-5-yl(piperidin-1-yl)methanone
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2] | Discontinued in Phase 1 | [1] | |
| Schizophrenia [ICD-11: 6A20] | Discontinued in Phase 1 | [1] | ||
| Company |
Cortex Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H13N3O2
|
|||
| Canonical SMILES |
C1CCN(CC1)C(=O)C2=CC3=NON=C3C=C2
|
|||
| InChI |
1S/C12H13N3O2/c16-12(15-6-2-1-3-7-15)9-4-5-10-11(8-9)14-17-13-10/h4-5,8H,1-3,6-7H2
|
|||
| InChIKey |
XFVRBYKKGGDPAJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 211735-76-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012259) | |||
| REF 2 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.